NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors Initiates first-in-human clinical studies of an IgG-like CD3 bispecific ...
New Delhi, Feb 6 (PTI) Zydus Lifesciences on Friday said the US health regulator has granted Orphan Drug Designation to Desidustat, a novel oral product medication for the treatment of Sickle Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results